1. Home
  2. NBTX

as of 12-10-2025 10:16am EST

$22.72
+$1.45
+6.82%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Chart Type:
Time Range:
Founded: 2003 Country:
France
France
Employees: N/A City: N/A
Market Cap: 1.0B IPO Year: 2020
Target Price: $8.00 AVG Volume (30 days): 46.3K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.28 EPS Growth: N/A
52 Week Low/High: $2.82 - $30.35 Next Earning Date: 09-30-2025
Revenue: $11,930,711 Revenue Growth: -75.93%
Revenue Growth (this year): N/A Revenue Growth (next year): 136.64%

AI-Powered NBTX Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 17 hours ago

AI Recommendation

hold
Model Accuracy: 71.11%
71.11%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: